173 related articles for article (PubMed ID: 9028328)
21. Cyclin D1 by flow cytometry as a useful tool in the diagnosis of B-cell malignancies.
Elnenaei MO; Jadayel DM; Matutes E; Morilla R; Owusu-Ankomah K; Atkinson S; Titley I; Mandala EM; Catovsky D
Leuk Res; 2001 Feb; 25(2):115-23. PubMed ID: 11166826
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of cyclin D1 in mantle cell lymphoma and other non-Hodgkin's lymphomas.
Aguilera NS; Bijwaard KE; Duncan B; Krafft AE; Chu WS; Abbondanzo SL; Lichy JH; Taubenberger JK
Am J Pathol; 1998 Dec; 153(6):1969-76. PubMed ID: 9846986
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of the PRAD1 oncogene in a patient with multiple myeloma and t(11;14)(q13;q32).
Kobayashi H; Saito H; Kitano K; Kiyosawa K; Gaun S; Aoki K; Narita A; Watanabe M; Uchimaru K; Motokura T
Acta Haematol; 1995; 94(4):199-203. PubMed ID: 8610478
[TBL] [Abstract][Full Text] [Related]
24. Cyclin D1 overexpression in malignant lymphomas.
Nakamura S; Yatabe Y; Seto M
Pathol Int; 1997 Jul; 47(7):421-9. PubMed ID: 9234379
[TBL] [Abstract][Full Text] [Related]
25. Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas.
Wlodarska I; Dierickx D; Vanhentenrijk V; Van Roosbroeck K; Pospísilová H; Minnei F; Verhoef G; Thomas J; Vandenberghe P; De Wolf-Peeters C
Blood; 2008 Jun; 111(12):5683-90. PubMed ID: 18391076
[TBL] [Abstract][Full Text] [Related]
26. Expression of cyclin D1 protein in centrocytic/mantle cell lymphomas with and without rearrangement of the BCL1/cyclin D1 gene.
Swerdlow SH; Yang WI; Zukerberg LR; Harris NL; Arnold A; Williams ME
Hum Pathol; 1995 Sep; 26(9):999-1004. PubMed ID: 7545645
[TBL] [Abstract][Full Text] [Related]
27. Characterization of chromosome 11 translocation breakpoints at the bcl-1 and PRAD1 loci in centrocytic lymphoma.
Williams ME; Swerdlow SH; Rosenberg CL; Arnold A
Cancer Res; 1992 Oct; 52(19 Suppl):5541s-5544s. PubMed ID: 1394169
[TBL] [Abstract][Full Text] [Related]
28. Cyclin D1 expression in mantle cell lymphoma is accompanied by downregulation of cyclin D3 and is not related to the proliferative activity.
Ott MM; Bartkova J; Bartek J; Dürr A; Fischer L; Ott G; Müller-Hermelink HK; Kreipe H
Blood; 1997 Oct; 90(8):3154-9. PubMed ID: 9376597
[TBL] [Abstract][Full Text] [Related]
29. The positive nuclear staining observed with monoclonal antibody against PRAD1/cyclin D1 correlates with mRNA expression in mantle cell lymphoma.
Kuroda H; Komatsu H; Nakamura S; Niitsu Y; Takahashi T; Ueda R; Seto M
Jpn J Cancer Res; 1995 Sep; 86(9):890-8. PubMed ID: 7591969
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of the PRAD1 oncogene in a patient with prolymphocytic leukemia with t(11;14)(q13;q32).
Kobayashi H; Kitano K; Saito H; Aoki K; Narita A; Terada N; Sonoyama M; Uchimaru K; Machii T; Motokura T
Cancer Genet Cytogenet; 1995 Oct; 84(1):69-72. PubMed ID: 7497446
[TBL] [Abstract][Full Text] [Related]
31. In situ hybridization detection of cyclin D1 mRNA in centrocytic/mantle cell lymphoma.
Williams ME; Nichols GE; Swerdlow SH; Stoler MH
Ann Oncol; 1995 Mar; 6(3):297-9. PubMed ID: 7612496
[TBL] [Abstract][Full Text] [Related]
32. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
[TBL] [Abstract][Full Text] [Related]
33. Over-expression of cyclin D1 in chronic B-cell malignancies with abnormality of chromosome 11q13.
Delmer A; Ajchenbaum-Cymbalista F; Tang R; Ramond S; Faussat AM; Marie JP; Zittoun R
Br J Haematol; 1995 Apr; 89(4):798-804. PubMed ID: 7772515
[TBL] [Abstract][Full Text] [Related]
34. Immunostaining of PRAD1/cyclin D1 protein as a marker for the diagnosis of mantle cell lymphoma.
Nakamura S; Yatabe Y; Kuroda H; Ueda R; Takahashi T; Suchi T; Seto M
Leukemia; 1997 Apr; 11 Suppl 3():536-7. PubMed ID: 9209449
[TBL] [Abstract][Full Text] [Related]
35. Selective usage of D-Type cyclins by Ewing's tumors and rhabdomyosarcomas.
Zhang J; Hu S; Schofield DE; Sorensen PH; Triche TJ
Cancer Res; 2004 Sep; 64(17):6026-34. PubMed ID: 15342383
[TBL] [Abstract][Full Text] [Related]
36. Cyclin D1 protein expression in mantle cell lymphoma.
Alkan S; Schnitzer B; Thompson JL; Moscinski LC; Ross CW
Ann Oncol; 1995 Jul; 6(6):567-70. PubMed ID: 8573535
[TBL] [Abstract][Full Text] [Related]
37. Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma.
de Boer CJ; Schuuring E; Dreef E; Peters G; Bartek J; Kluin PM; van Krieken JH
Blood; 1995 Oct; 86(7):2715-23. PubMed ID: 7670110
[TBL] [Abstract][Full Text] [Related]
38. PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma.
Bosch F; Jares P; Campo E; Lopez-Guillermo A; Piris MA; Villamor N; Tassies D; Jaffe ES; Montserrat E; Rozman C
Blood; 1994 Oct; 84(8):2726-32. PubMed ID: 7919385
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibody against PRAD1/cyclin D1 stains nuclei of tumor cells with translocation or amplification at BCL-1 locus.
Banno S; Yoshikawa K; Nakamura S; Yamamoto K; Seito T; Nitta M; Takahashi T; Ueda R; Seto M
Jpn J Cancer Res; 1994 Sep; 85(9):918-26. PubMed ID: 7961120
[TBL] [Abstract][Full Text] [Related]
40. Messenger RNA levels of five genes located at chromosome 11q13 in B-cell tumors with chromosome translocation t(11;14)(q13;q32).
Akiyama N; Tsuruta H; Sasaki H; Sakamoto H; Hamaguchi M; Ohmura Y; Seto M; Ueda R; Hirai H; Yazaki Y
Cancer Res; 1994 Jan; 54(2):377-9. PubMed ID: 8275473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
